THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTSelecta Biosciences Inc • June 28th, 2017 • Pharmaceutical preparations • Massachusetts
Warrant No. CS-01 Number of Shares: 79,130 (subject to adjustment) Date of Issuance: June 27, 2017 Original Issue Date (as defined in subsection 2(a)): June 27, 2017
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 28th, 2017 • Selecta Biosciences Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 27, 2017 by and among Selecta Biosciences, Inc., a Delaware corporation (the “Company”), and the “Investors” named in the: (i) Securities Purchase Agreement, dated June 26, 2017, by and among the Company and the Investors identified on Exhibit A attached thereto (the “Investors’ Purchase Agreement”) and (ii) Securities Purchase Agreement, dated June 26, 2017, between the Company and Timothy Springer, Ph.D. (the “Springer Purchase Agreement” and, together with the Investors’ Purchase Agreement, the “Purchase Agreements”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreements unless otherwise defined herein.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 28th, 2017 • Selecta Biosciences Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 26, 2017 by and among Selecta Biosciences, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
